pc14586
pmv pharmaceuticals
['solid tumor', 'pc14586 ', 'pmv pharma', 'pmv,pharmaceuticals']
pmv pharmaceuticals initial pc14586 phase 1 data presented at asco demonstrated anti-tumor activity across multiple solid tumor types with a p53 y220c mutation - response rate (orr) of 32% (8/25) achieved in higher dose cohorts per recist v1.1partial re... 
CEO Of Digital Media Online